8-K
filed October 2, 2023, 7:59 PM ET
CIK 0001689657
M&A
confidence high
sentiment neutral
materiality 1.00
PhenomeX Inc.: M&A transaction — Bruker closes $1.00/share all-cash acquisition of PhenomeX; delisting from Nasdaq
PhenomeX Inc.
- Bruker Corp. acquired PhenomeX for $1.00/share in cash; 81.5% of outstanding shares (81.3M) tendered in the offer.
- All remaining shares, options, RSUs, and restricted stock converted to cash at $1.00/share; appraisal rights available.
- Former CEO Siddhartha Kadia and all prior directors/officers replaced; Mark Munch appointed President.
- Company renamed Bruker Cellular Analysis, Inc.; Nasdaq delisting and SEC deregistration requested.
- Amended certificate of incorporation and bylaws filed with Delaware Secretary of State effective Oct 2, 2023.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Peter Silvester departed as Director at PhenomeX Inc..
- Action
- ceased to be a director
- Role
- Director
Exact text from the filing
Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Greg Lucier departed as Director at PhenomeX Inc..
- Action
- ceased to be a director
- Role
- Director
Exact text from the filing
Greg Lucier, Jessica Hopfield, Elizabeth Nelson, Michael Mortitz, Igor Khandros, John Chiminski, and Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Igor Khandros departed as Director at PhenomeX Inc..
- Action
- ceased to be a director
- Role
- Director
Exact text from the filing
Igor Khandros, John Chiminski, and Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Mark Munch was appointed as Director at PhenomeX Inc..
- Action
- became a director
- Role
- Director
Exact text from the filing
each of Mark Munch, Gerald Herman and Brent Alldredge became a director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Mark Munch was appointed as other_named_officer at PhenomeX Inc..
- Action
- became an executive officer
Exact text from the filing
each of Mark Munch, Brent Alldredge, and Jie Kong became the executive officers of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Elizabeth Nelson departed as Director at PhenomeX Inc..
- Action
- ceased to be a director
- Role
- Director
Exact text from the filing
Elizabeth Nelson, Michael Mortitz, Igor Khandros, John Chiminski, and Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Brent Alldredge was appointed as other_named_officer at PhenomeX Inc..
- Action
- became an executive officer
Exact text from the filing
each of Mark Munch, Brent Alldredge, and Jie Kong became the executive officers of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jie Kong was appointed as other_named_officer at PhenomeX Inc..
- Action
- became an executive officer
Exact text from the filing
each of Mark Munch, Brent Alldredge, and Jie Kong became the executive officers of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Siddhartha Kadia departed as Director at PhenomeX Inc..
- Action
- ceased to be a director
- Role
- Director
Exact text from the filing
Siddhartha Kadia, Greg Lucier, Jessica Hopfield, Elizabeth Nelson, Michael Mortitz, Igor Khandros, John Chiminski, and Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
John Chiminski departed as Director at PhenomeX Inc..
- Action
- ceased to be a director
- Role
- Director
Exact text from the filing
John Chiminski, and Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jessica Hopfield departed as Director at PhenomeX Inc..
- Action
- ceased to be a director
- Role
- Director
Exact text from the filing
Jessica Hopfield, Elizabeth Nelson, Michael Mortitz, Igor Khandros, John Chiminski, and Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Mortitz departed as Director at PhenomeX Inc..
- Action
- ceased to be a director
- Role
- Director
Exact text from the filing
Michael Mortitz, Igor Khandros, John Chiminski, and Peter Silvester, each a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and members of any committee of the Company’s Board of Directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Gerald Herman was appointed as Director at PhenomeX Inc..
- Action
- became a director
- Role
- Director
Exact text from the filing
each of Mark Munch, Gerald Herman and Brent Alldredge became a director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Brent Alldredge was appointed as Director at PhenomeX Inc..
- Action
- became a director
- Role
- Director
Exact text from the filing
each of Mark Munch, Gerald Herman and Brent Alldredge became a director of the Company.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
PhenomeX Inc.: Bylaws amended and restated in their entirety in connection with the Merger, including to reflect the name change to Bruker Cellular Analysis, Inc (effective 2023-10-02).
- Change
- bylaw amendment
- Effective
- 2023-10-02
Exact text from the filing
the bylaws of the Company were amended and restated in their entirety, including to reflect the Name Change
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
PhenomeX Inc.: Certificate of incorporation amended and restated in its entirety in connection with the Merger, including changing the company name to Bruker Cellular Analysis, Inc (effective 2023-10-02).
- Change
- charter amendment
- Effective
- 2023-10-02
Exact text from the filing
the Company’s certificate of incorporation as in effect immediately prior to the Merger was amended and restated in its entirety
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
PhenomeX Inc. underwent a change of control involving Bruker Corporation for $1.00 per Share (closed 2023-10-02).
- Action
- change of control
- Counterparty
- Bruker Corporation
- Consideration
- $1.00 per Share
- Closing
- 2023-10-02
Exact text from the filing
☐ Introductory Note On October 2, 2023, Bruker Corporation, a Delaware corporation (“ Parent ”), completed its previously announced acquisition of PhenomeX Inc., a Delaware corporation (the “ Company ”), pursuant to the Agreement and Plan of Merger, dated as of August 17, 2023 (the “ Merger Agreement ”), by and among the Company, Parent and Bird Mergersub Corporation, a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub ”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.